August 15, 2023·Kristofer Prepelica, PhD

Results from the PCCTC’s Randomized Phase 2 Trial of Abiraterone Acetate With or Without Cabazitaxel Published in The Journal of Clinical Oncology

Combination was safe with improved rPFS, OS duration, and a higher proportion ofPSA declines.

This item links to coverage published on an external site.